logo-loader
viewAkerna Corp

Full interview: Akerna 'widening its competitive moat' with targeted acquisition in anti-counterfeit technology

Akerna Corp (NASDAQ:KERN) CEO Jessica Billingsley tells Proactive the Denver, Colorado-based cannabis-focused regulatory compliance technology company is looking to 'widen its competitive moat' with recent investment into anti-counterfeit technology platform solo sciences inc.

Billingsley talks through the company's recent $18 million investment in privately-held solo sciences, and how important pursuing targeted M&A is for the company.

Quick facts: Akerna Corp

Price: 8.84 USD

NASDAQ:KERN
Market: NASDAQ
Market Cap: $96.88 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Revenue guidance from OptiBiotix as it eyes NASDAQ listing

OptiBiotix Health (LON:OPTI) provides a commercial progress update, explaining why in their financials some items are separated. CEO Stephen O'Hara tells Proactive London what's behind his thinking adding that Optibiotix hopes to reach profitability in 2020. News here too on Sweetbiotix and...

2 days, 15 hours ago

2 min read